Purpose: Ocular local anesthetics currently used in routine clinical practice for corneal anesthesia are short acting and their ability to delay corneal healing makes them unsuitable for long-term use. In this study, we examined the effect of the site 1 sodium channel blocker tetrodotoxin (TTX) on the duration of corneal anesthesia, applied with either proparacaine (PPC) or the chemical permeation enhancer octyl-trimethyl ammonium bromide (OTAB). The effect of test solutions on corneal healing was also studied.
O cular local anesthetics (OLAs) are routinely used in ophthalmology for short procedures. Currently used OLAs act by binding to an intracellular domain of the sodium channel. 1 The duration of action of typical OLAs, like proparacaine (PPC) and tetracaine, is generally between 10 and 20 minutes. 2 Their short durations of action and the potential for corneal toxicity 3 effectively excludes them from use in chronic pain conditions and for lengthier ophthalmic procedures. Fear of pain and inadequate pain relief are factors that may limit patient enthusiasm for surgical procedures, such as photorefractive keratectomy. 4 An effective topical pain-relieving formulation with extended effect is needed in ophthalmology. Ideally, such a formulation would last hours not minutes and could be used to prevent pain more effectively during surgical procedures.
Tetrodotoxin (TTX) and saxitoxin are site 1 sodium channel blockers that induce local anesthesia by binding to site 1 on the extracellular part of the sodium channel. [5] [6] [7] When combined with amino ester or amino amide local anesthetics, [7] [8] [9] or chemical permeation enhancers (CPEs), 10 site 1 sodium channel blockers demonstrate a synergistic effect on local anesthesia. Corneal analgesia from topical application of TTX has been previously reported, 11 with minimal toxicity to the corneal epithelium. 12 We hypothesized that combining site 1 sodium channel blocker and a typical OLA, such as PPC, with or without a CPE would result in prolonged corneal anesthesia with toxicity to the corneal epithelium similar to or less than that from PPC alone.
MATERIALS AND METHODS

Animal Care
Adult male Sprague-Dawley rats (Charles River laboratories International, Inc, Wilmington, MA) weighing 300 to 350 g were housed in pairs, allowed standard rat diet and water ad libitum, and maintained on a 7 AM to 7 PM light-dark cycle. Animal studies were conducted using protocols approved by the Massachusetts Institute of Technology Committee on Animal Care and in accordance with the Association for Research in Vision and Ophthalmology statement on the use of animals in ophthalmic research. Rats were chosen at random for inclusion into specific treatment groups.
Drugs and Reagents
Octyl trimethyl ammonium bromide (OTAB) and PPC were obtained from Sigma-Aldrich Corp (St Louis, MO), and solutions were prepared in 0.9% saline, whereas tetrodotoxin citrate (Tocris Bioscience, Ellisville, MO) solutions were prepared in 20 mM citrate solution (pH, 4.5). All drug solutions were prepared immediately before the administration. The volume of drug or drug combination that was topically applied on the cornea was 30 mL. For in vitro cell viability assay, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) and phenazine methosulfate were purchased from Promega Corp (Madison, WI). All materials were used as received unless stated otherwise.
Cell Viability Assay
Immortalized human corneal limbal epithelial (HCLE) cells and immortalized human corneal keratocytes (corneal fibroblasts) were generous gifts from Dr Ilene Gipson (Schepens Eye Research Center, Harvard Medical School, Boston, MA). HCLE were cultured in keratinocyte serum-free medium (Invitrogen, Carlsbad, CA) supplemented with epidermal growth factor and bovine pituitary extract, until cells reached 50% confluence, and then, culturing medium was switched to a 1:1 mixture of keratinocyte serum-free medium and a combination of 1:1 unsupplemented low-calcium Dulbecco's minimum essential medium (DMEM) and F12 Ham's nutrient mixture (Invitrogen). For differentiation and stratification, HCLE cells were exposed to 1:1 DMEM/F12 medium (Mediatech, Manassas, VA) supplemented with newborn calf serum and epidermal growth factor.
Corneal keratocytes were cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. All cells were incubated at 37°C in a 5% CO 2 environment.
Corneal keratocytes and differentiated HCLE cells were exposed to media containing (in millimoles) 15 PPC and 1, 3, and 6 TTX, and cellular viability was assessed after 4, 8, 16, and 24 hours, using the MTS colorimetric assay (CellTiter96 Proliferation Assay; Promega, Fitchburg, WI). Results are presented as percent viability from 4 separate experiments, normalized to cultured cells that did not receive drug exposure.
Assessment of Corneal Touch Sensitivity in Rats
Towel-restrained rats received drugs in the form of topical drops to the left eye, while the right eye served as untreated control. All animals received a single administration of test solutions (Table 1) in a volume of 30 mL, unless mentioned otherwise. Corneal tactile sensitivity was tested using a Cochet-Bonnet esthesiometer 13 (Luneau Ophtalmologie, Chartres, France), which consists of a retractable nylon monofilament that exerts pressure inversely proportional to its length. At full extension, the monofilament is 6 cm in length with a diameter of 0.12 mm. Testing began by gently placing the tip of the fully extended filament perpendicularly to the cornea, followed by application of sufficient force to slightly buckle the filament. A reflexive blink was considered a positive response. In the absence of blink response, the filament length was reduced by 0.5 cm, and the animal retested. The process of filament length Groups were compared using 1-way analysis of variance with Bonferroni post hoc test. Block 0.5, 2, ,6 represents the duration of absent blink response when the cornea was probed with filament length of 0.5 cm (complete blocks), 2 cm (dense blocks), and 6 cm (any degree of block; time to block resolution), respectively. Data are represented as mean 6 SD (n = 4). *P , 0.05 compared with 15 mM PPC. †P , 0.05, compared with rats administered TTX only within each TTX concentration group. ‡P , 0.05, compared with rats coadministered TTX and PPC within each TTX concentration group.
reduction and retesting was repeated until a positive response was elicited. Both eyes were tested in this manner at least 3 times. Animals were tested 10, 20, and 30 minutes after the administration of drops, then every hour for the next 12 hours. Duration of nonresponsiveness to filament length of 0.5 cm (block 0.5 ) was defined as the duration of complete corneal block. Similarly, nonresponsiveness to 2 cm (block 2 ) and 2 to 5 cm (block ,6 ) was considered as the duration of dense and partial corneal block, respectively.
Corneal Debridement Studies
To assess the effect of TTX and/or PPC on the rate of cornea epithelialization, rats were anesthetized with 2% isoflurane and 98% oxygen inhalation. A corneal trephine (3-mm diameter) was placed on the left cornea and filled with 50% ethanol for 90 seconds. This resulted in loosening and detachment of the ethanol-soaked cornea within the trephine. Care was taken to ensure no ethanol leaked outside the trephine. The eye was flushed with warm saline, and the detached cornea was gently scraped away using a sterile surgical blade. 14 Immediately after the lesion was made, a single dose of 30 mL of the drug solution was placed in the wounded eye. Photographs were taken after fluorescein (FUL-GLO strips; Akorn, Inc, Lake forest, IL) instillation, using a Nikon D60 camera with a 60 mm f/2.8 Micro-Nikkor lens and an attached 8 yellow lens filter (Tiffen Company, Hauppauge, NY), every 4 hours till complete reepithelialization. An external light source with a cobalt blue filter was used to better visualize the fluorescein filled corneal defect. All images were analyzed using ImageJ software (National Institutes of Health, Bethesda, MD) for corneal wound area estimation. The rate of corneal epithelialization was calculated using the following formula:
Statistical Analysis
Data are presented as means 6 SDs of N observations unless noted otherwise. All in vitro assays were done in duplicate, and each experiment was repeated 4 times (n = 4), and the average was considered for statistical analysis. Statistical differences in mean corneal block duration and average rate of corneal wound healing between the experimental groups were compared using 1-way analysis of variance with Bonferroni post hoc test. Data from in vitro analysis at various time points were compared using 2-way analysis of variance with Bonferroni post hoc test; P , 0.05 was considered statistically significant. All analyses were performed using GraphPad Prism version 5.0c for Mac OSX (GraphPad Software, San Diego, CA).
RESULTS
Topical Coapplication of TTX and PPC Prolongs Corneal Analgesia
To determine whether drug combinations could yield prolonged corneal anesthesia with less corneal toxicity, we compared the duration of corneal block obtained by topical application of 15 mM PPC on the rat cornea with blocks obtained by the application of varying concentrations of TTX with or without OTAB (a CPE that has been previously demonstrated to prolong TTX-induced nerve conduction blocks 10, 15 ) ( Table 1) . A concentration of 15 mM PPC (0.5% wt/vol) was used throughout because it is commonly used in clinical applications. 3 All drug and drug combinations were administered in a volume of 30 mL into the inferior conjunctival cul-de-sac, after retraction of the lower eyelid. This volume completely saturated the cornea, with minimal overflow.
Corneal sensitivity to tactile stimulation was tested by recording the blink reflex in response to gentle probing of the central corneal surface using the Cochet-Bonnet esthesiometer. 13 A filament length of 6 cm (maximum length) is least painful on contact, whereas a shorter, stiffer filament length of 0.5 cm (the shortest) is most painful. Naive (no local anesthetic treatment) rats exhibited the normal blink response at 5 to 6 cm. Dense corneal block was defined as the absence of blink reflex in response to a filament length of 2 cm (block 2 ), whereas nonresponsiveness to filament lengths of 2 to 5 cm was considered as partial block (Block ,6 ). Lack of response to the minimum filament length of 0.5 cm was termed complete block. The duration of block 0.5 , block 2 , or block ,6 (equivalent to time to return of normal function) was calculated starting from the time of drug administration.
Topical application of 15 mM PPC produced block 2 that lasted approximately 20 minutes (Table 1 ). Although 0.1 mM TTX failed to produce dense blocks (block 2 = 0 min), 1, 3, and 6 mM TTX produced block 2 that were similar in duration (P . 0.05; n = 4) to 15 mM PPC. However coadministration of 1, 3, or 6 mM TTX with 15 mM PPC produced block 2 that were considerably longer (7-8 fold; P , 0.05; n = 4) than either drug concentration administered individually. Nonetheless, the prolongation of block 2 from the combination of PPC and TTX did not increase with increasing concentration of TTX beyond 1 mM (P . 0.05) ( Table 1 ). Coadministration of OTAB did not increase block 2 from PPC, TTX, or their combinations (P . 0.05).
Similar to what was seen with block 2 , the combination of PPC and varying concentrations of TTX produced block ,6 that were significantly longer than those from individual drugs. However, coadministration of lower concentration of OTAB (0.1 and 1 mM) did not prolong block ,6 of PPC and TTX (P , 0.05), Rate of re-epithelialization ¼ Area of wound immediately after debridement À mm 2 Á Total time for complete healing ðhÞ whereas higher concentration of OTAB (3 and 6 mM) produced significant prolongation. In all groups, the untreated eye exhibited no changes in corneal sensitivity.
Topical application of 15 mM PPC produced corneal blocks that reached complete insensitivity (block 0.5 ) for approximately 15 minutes. For each TTX concentration, the duration of analgesia from the combination with PPC was longer than from PPC alone (P , 0.05; n = 4), even though only 1 of 4 rats tested achieved complete insensitivity. Addition of OTAB to combinations of TTX and PPC did not further enhance block 0.5 at any of the concentrations tested (Table 1) (P . 0.05, compared with respective concentration of coadministered TTX and PPC).
Higher Concentrations of TTX Decrease Cellular Viability
To determine the cytotoxicity of TTX, HCLE cells ( Fig. 1A) and human corneal keratocytes (corneal fibroblasts) ( Fig. 1B) were incubated in media containing 0.1, 1, 3, and 6 mM of TTX or 15 mM PPC. Exposure of corneal fibroblasts and epithelial cells to 15 mM PPC for 4 hours resulted in 60% to 70% loss of cellular viability and by 24 hours, only 10% of the cells survived ( Fig. 1A, B ; P , 0.05) compared with the viability of cells exposed to citrate buffer alone (the carrier for all test solutions) at all time points tested (n = 3). Similarly, cells exposed to 6 mM TTX demonstrated decreased cell viability compared with citrate buffer-exposed cells (P , 0.05; n = 3) at all time points tested. In contrast, cells exposed to lower concentrations of TTX (0.1, 1, and 3 mM) exhibited viability similar to that of vehicle-treated cells at all time points (P . 0.05; n = 3).
Coapplication of TTX and PPC Delays the Rate of Corneal Healing
PPC is known to cause corneal epithelial toxicity and delayed healing. 16 To assess whether the combination of TTX with PPC alters corneal healing, we monitored the rate of corneal epithelialization after debridement of 12 to 14 mm 2 of the corneal epithelial layer ( Fig. 2A) . Drug solutions were applied topically immediately after the debridement procedure.
The rate of reepithelialization was decreased by approximately 18% (over a period of 36 hours) by a single dose of 15 mM PPC, which was not significantly different from the reepithelialization rate in saline-treated eyes (P . 0.05; n = 4; Fig. 2B ). TTX at 1 and 6 mM also exhibited corneal reepithelialization rates that were similar (P . 0.05; n = 4) to saline-treated corneas. However, the rate of corneal reepithelialization was decreased after the coadministration of 15 mM PPC with 1 mM TTX (P , 0.05, n = 5) compared with saline-administered rats (Fig. 2B and 3 ).
DISCUSSION
The synergistic action of site 1 sodium channel blockers with amino amide and amino ester local anesthetics in the peripheral nerve has been described by others 17, 18 and by us. 7, 9, 19 Coadministration of bupivacaine with TTX, as a sciatic nerve block injection, produces conduction blocks that are 3 to 4 times more prolonged than that from either drug alone. 9 In the rat cornea, we observed a similar enhancement of nerve blockade between TTX and the OLA PPC, which together produce corneal blocks that were approximately 7 to 8 times longer than those from the individual drugs. This interaction may be attributed to the fact that conventional local anesthetics block sodium channels from within the cell, whereas TTX acts on the extracellular part of the channel. 20 These combinations could provide approximately 3 hours of dense (block 2 ) anesthesia that might be suitable for sharp perioperative pain. Complete recovery of sensation took more than 6 hours, suggesting a useful dosing time frame for less intense nonsurgical pain.
Coadministering TTX and PPC also enhanced the intensity of block. This is important because PPC, a commonly used corneal numbing drug, produced complete block (block 0.5 ) for only 15 minutes, whereas the combination of Corneal anesthesia requires that the ocular anesthetic must penetrate the superficial epithelial layers and bind to the corneal nerve fibers. CPEs facilitate drug penetration across epithelial layers and can prolong TTX-induced peripheral nerve blockade. 10 Tetracaine, an ocular amino ester anesthetic, is a known CPE. 21 PPC, a drug related to tetracaine, could act as a CPE and promotes TTX binding to corneal sensory axons, thereby prolonging corneal block. However, addition of OTAB, a CPE, 10,15 did not prolong block from TTX, suggesting that PPC's prolongation of TTX block was unlikely to be a CPE effect. Because corneal nerve fibers extend to within a few cell layers of the corneal surface, 22 TTX by itself may be reaching nerve fibers easily, so that CPEs have no effect.
The use of high concentrations of TTX (compared with those used in peripheral nerve, 30-50 mm 7, 9 ) raises the issue of the potential systemic toxicity of that compound 23 if absorbed into a wound or inflammation, or after passage into the nasolacrimal duct. However, there were no clinical signs of toxicity in any of the rats in this study. Distribution of TTX within the anterior chamber is another potential concern. TTX does not affect intraocular pressure or change aqueous humor composition, 24 but its effects on other structures within the eye are yet to be determined.
The use of TTX for corneal analgesia has been reported. 11, 12, 25 In rabbits, topical application of 10 mM TTX produces corneal anesthesia for up to 8 hours. 11 In this study, rats exposed to 1 mM TTX (or higher concentrations) produced block ,6 corneal anesthesia for approximately 3 hours. The dissimilarity in duration of block between the current study and previous reports could be the result of differences in rat and rabbit corneal innervation. 26 In addition, we used the Cochet-Bonnet esthesiometer, whereas previous studies used a blink scoring system. 11, 25 FIGURE 2. Effect of drugs on rate of corneal reepithelialization. A, Representative black-and-white images of the rate of epithelial regrowth in surgically debrided cornea after topical application of saline and 1 mM TTX with 15 mM PPC. Images were taken under illumination with a UV lamp to show fluorescein applied to the cornea to enhance visualization of the wound. B, Effect of test compounds on the rate of corneal reepithelialization averaged over a period of 36 hours. Data are represented as mean 6 SD (n = 5). Groups were compared with saline-treated controls using 1-way analysis of variance with Bonferroni post hoc test (*P , 0.05). TTX caused concentration-dependent corneal cytotoxicity in vitro, whereas the same concentrations caused only a mild decrease in corneal epithelial proliferation in vivo. Coapplication of a single dose of 1 mM TTX and 15 mM PPC significantly decreased corneal reepithelialization, whereas similar concentrations of TTX and PPC administered separately did not significantly alter corneal reepithelialization. The mechanism for this difference is not clear, but it has been observed that denervation delays corneal healing. 27 Coapplication of TTX and PPC could hinder corneal healing by inhibiting neural feedback; our data suggest a relationship between the duration of block and the rate of reepithelialization ( Fig. 3 ). If that is correct, it is interesting that a relatively brief period of blockade would have a lasting effect on wound healing. These findings underscore the need for further investigation of the impact of local anesthetics, including those described here, in models of corneal analgesia.
In conclusion, the combination of TTX and PPC can be used to produce corneal anesthesia of much longer duration than PPC or TTX alone. However, in view of potential corneal toxicity, caution should be exercised in their use in the context of existing injury.
